Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/24/2020 Oct/27/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/22/2020 Oct/27/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Oct/20/2020 Oct/26/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/20/2020 Oct/29/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/27/2020 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/14/2020 Oct/05/2020 0
Sarilumab  Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/01/2020 Aug/25/2020 0
Emtricitabine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/23/2020 Jun/29/2020 0